{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:43:48Z","timestamp":1791863028197,"version":"4.3.4"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Microbiol Biotechnol"],"DOI":"10.1007\/s11274-026-04850-z","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T01:54:04Z","timestamp":1773107644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multiple virulence attenuating strategies against Pseudomonas aeruginosa: Natural, synthetic, and synergistic approaches"],"prefix":"10.1007","volume":"42","author":[{"given":"Mulugeta","family":"Mulat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Tabassum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taehyeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazlurrahman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"4850_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/456463","volume":"2015","author":"SH Abdel-Rhman","year":"2015","unstructured":"Abdel-Rhman SH, El-Mahdy AM, El-Mowafy M (2015) Effect of tyrosol and farnesol on virulence and antibiotic resistance of clinical isolates of Pseudomonas aeruginosa. BioMed Res Int 2015:456463. https:\/\/doi.org\/10.1155\/2015\/456463","journal-title":"BioMed Res Int"},{"issue":"1","key":"4850_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-023-02122-1","volume":"22","author":"AA Abdelaziz","year":"2023","unstructured":"Abdelaziz AA, Kamer AMA, Al-Monofy KB, Al-Madboly LA (2023) Pseudomonas aeruginosa\u2019s greenish-blue pigment pyocyanin: its production and biological activities. Microb Cell Fact 22(1):110. https:\/\/doi.org\/10.1186\/s12934-023-02122-1","journal-title":"Microb Cell Fact"},{"key":"4850_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-025-05295-2","author":"T Akter","year":"2025","unstructured":"Akter T, Challita P-M, Haider AM, Islam S, Fatema K, Stapleton F, Willcox M (2025) Structural and functional insights into Pseudomonas aeruginosa\u2019s secretion systems 1\u20136: regulation, role in microbial keratitis and drug targets. Eur J Clin Microbiol Infect Dis. https:\/\/doi.org\/10.1007\/s10096-025-05295-2","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"4850_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-024-03712-8","volume":"25","author":"LA Al-Maddboly","year":"2025","unstructured":"Al-Maddboly LA, El-Salam MA, Bastos JK, Hasby EA, Kushkevych I, El-Morsi RM (2025) Anti-biofilm and anti-quorum sensing activities of galloylquinic acid against clinical isolates of multidrug-resistant Pseudomonas aeruginosa in open wound infection: in vitro and in vivo efficacy studies. BMC Microbiol 25(1):206. https:\/\/doi.org\/10.1186\/s12866-024-03712-8","journal-title":"BMC Microbiol"},{"issue":"6","key":"4850_CR5","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1128\/aac.00235-13","volume":"57","author":"M Alhajlan","year":"2013","unstructured":"Alhajlan M, Alhariri M, Omri A (2013) Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors. Antimicrob Agents Chemother 57(6):2694\u20132704. https:\/\/doi.org\/10.1128\/aac.00235-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4850_CR6","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2025.2580160","volume":"16","author":"MS Alharbi","year":"2025","unstructured":"Alharbi MS, Moursi SA, Alshammari A, Aboras R, Rakha E, Hossain A, Alshubrumi S, Alnazha K, Khaja ASS, Saleem M (2025) Multidrug-resistant Pseudomonas aeruginosa: pathogenesis, resistance mechanisms, and novel therapeutic strategies. Virulence 16(1):2580160. https:\/\/doi.org\/10.1080\/21505594.2025.2580160","journal-title":"Virulence"},{"issue":"5","key":"4850_CR7","doi-asserted-by":"publisher","first-page":"629e621","DOI":"10.1016\/j.cmi.2018.08.004","volume":"25","author":"SO Ali","year":"2019","unstructured":"Ali SO, Yu XQ, Robbie GJ, Wu Y, Shoemaker K, Yu L, DiGiandomenico A, Keller AE, Anude C, Hernandez-Illas M, Bellamy T, Falloon J, Dubovsky F, Jafri HS (2019) Phase 1 study of MEDI3902, an investigational anti-Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults. Clin Microbiol Infect 25(5):629e621-629e626. https:\/\/doi.org\/10.1016\/j.cmi.2018.08.004","journal-title":"Clin Microbiol Infect"},{"key":"4850_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2025.102111","volume":"43","author":"EU Alum","year":"2025","unstructured":"Alum EU, Gulumbe BH, Izah SC, Uti DE, Aja PM, Igwenyi IO, Offor CE (2025) Natural product-based inhibitors of quorum sensing: a novel approach to combat antibiotic resistance. Biochem Biophys Rep 43:102111. https:\/\/doi.org\/10.1016\/j.bbrep.2025.102111","journal-title":"Biochem Biophys Rep"},{"issue":"1","key":"4850_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13568-025-01835-3","volume":"15","author":"OY Alyahyawy","year":"2025","unstructured":"Alyahyawy OY, Munshi RM, Badr-Eldin SM, Aldawsari HM, Abualsunun W, Abbas HA, Salem IM, Hegazy WAH, Nazeih SI (2025) Reprofiling lamivudine as an antibiofilm and anti-pathogenic agent against Pseudomonas aeruginosa. AMB Express 15(1):33. https:\/\/doi.org\/10.1186\/s13568-025-01835-3","journal-title":"AMB Express"},{"issue":"1","key":"4850_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-025-10270-3","volume":"52","author":"N Arami","year":"2025","unstructured":"Arami N, Tajani AS, Hashemi M, Rezaei T, Ghodsi R, Soheili V, Bazzaz BSF (2025) Targeted inhibition of PqsR in Pseudomonas aeruginosa PAO1 quorum-sensing network by chalcones as promising antibacterial compounds. Mol Biol Rep 52(1):175. https:\/\/doi.org\/10.1007\/s11033-025-10270-3","journal-title":"Mol Biol Rep"},{"key":"4850_CR11","unstructured":"Araos R, D\u2019Agata E (2019) Pseudomonas aeruginosa and other Pseudomonas species"},{"issue":"1","key":"4850_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-017-0208-x","volume":"6","author":"JA Ayukekbong","year":"2017","unstructured":"Ayukekbong JA, Ntemgwa M, Atabe AN (2017) The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control 6(1):47. https:\/\/doi.org\/10.1186\/s13756-017-0208-x","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"4850_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-00005-6","volume":"15","author":"M Azimzadeh","year":"2025","unstructured":"Azimzadeh M, Greco G, Farmani A, Nourian A, Pourhajibagher M, Taherkhani A, Alikhani MY, Bahador A (2025) Biofilm inhibition of multidrug-resistant Pseudomonas aeruginosa using green-synthesized silver nanoparticles and colistin. Sci Rep 15(1):14993. https:\/\/doi.org\/10.1038\/s41598-025-00005-6","journal-title":"Sci Rep"},{"issue":"1","key":"4850_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gks1039","volume":"41","author":"D Balasubramanian","year":"2013","unstructured":"Balasubramanian D, Schneper L, Kumari H, Mathee K (2013) A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res 41(1):1\u201320. https:\/\/doi.org\/10.1093\/nar\/gks1039","journal-title":"Nucleic Acids Res"},{"key":"4850_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1264773","volume":"10","author":"F Ballante","year":"2023","unstructured":"Ballante F, Turkina MV, Ntzouni M, Magnusson KE, Vikstr\u00f6m E (2023) Modified N-acyl-L-homoserine lactone compounds abrogate Las-dependent quorum-sensing response in human pathogen Pseudomonas aeruginosa. Front Mol Biosci 10:1264773. https:\/\/doi.org\/10.3389\/fmolb.2023.1264773","journal-title":"Front Mol Biosci"},{"issue":"10","key":"4850_CR16","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1167\/iovs.06-0288","volume":"47","author":"MB Bandara","year":"2006","unstructured":"Bandara MB, Zhu H, Sankaridurg PR, Willcox MD (2006) Salicylic acid reduces the production of several potential virulence factors of Pseudomonas aeruginosa associated with microbial keratitis. Invest Ophthalmol Vis Sci 47(10):4453\u20134460. https:\/\/doi.org\/10.1167\/iovs.06-0288","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"4850_CR17","doi-asserted-by":"publisher","first-page":"10723","DOI":"10.1021\/nn5044383","volume":"8","author":"A Beaussart","year":"2014","unstructured":"Beaussart A, Baker AE, Kuchma SL, El-Kirat-Chatel S, O\u2019Toole GA, Dufr\u00eane YF (2014) Nanoscale adhesion forces of Pseudomonas aeruginosa type IV Pili. ACS nano 8(10):10723\u201310733. https:\/\/doi.org\/10.1021\/nn5044383","journal-title":"ACS nano"},{"key":"4850_CR18","doi-asserted-by":"publisher","unstructured":"Bernab\u00e8 G, Marzaro G, Di Pietra G, Otero A, Bellato M, Pauletto A, Scarpa M, Sut S, Chilin A, Dall\u2019Acqua S, Brun P, Castagliuolo I (2022) A novel phenolic derivative inhibits AHL-dependent quorum sensing signaling in Pseudomonas aeruginosa . 13\u20132022. Frontiers in pharmacology https:\/\/doi.org\/10.3389\/fphar.2022.996871","DOI":"10.3389\/fphar.2022.996871"},{"key":"4850_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27030699","author":"AT Bernal-Mercado","year":"2022","unstructured":"Bernal-Mercado AT, Juarez J, Valdez MA, Ayala-Zavala JF, Del-Toro-S\u00e1nchez CL, Encinas-Basurto D (2022) Hydrophobic chitosan nanoparticles loaded with carvacrol against Pseudomonas aeruginosa biofilms. Molecules. https:\/\/doi.org\/10.3390\/molecules27030699","journal-title":"Molecules"},{"issue":"2","key":"4850_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2217\/fmb-2019-0204","volume":"15","author":"SK Bose","year":"2020","unstructured":"Bose SK, Chauhan M, Dhingra N, Chhibber S, Harjai K (2020) Terpinen-4-ol attenuates quorum sensing regulated virulence factors and biofilm formation in Pseudomonas aeruginosa. Future Microbiol 15(2):127\u2013142. https:\/\/doi.org\/10.2217\/fmb-2019-0204","journal-title":"Future Microbiol"},{"issue":"4","key":"4850_CR21","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1128\/aac.02795-13","volume":"58","author":"NO Bowlin","year":"2014","unstructured":"Bowlin NO, Williams JD, Knoten CA, Torhan MC, Tashjian TF, Li B, Aiello D, Mecsas J, Hauser AR, Peet NP, Bowlin TL, Moir DT (2014) Mutations in the Pseudomonas aeruginosa needle protein gene pscF confer resistance to phenoxyacetamide inhibitors of the type III secretion system. Antimicrob Agents Chemother 58(4):2211\u20132220. https:\/\/doi.org\/10.1128\/aac.02795-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"4850_CR22","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1128\/aac.00776-10","volume":"55","author":"GR Cathcart","year":"2011","unstructured":"Cathcart GR, Quinn D, Greer B, Harriott P, Lynas JF, Gilmore BF, Walker B (2011) Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection. Antimicrob Agents Chemother 55(6):2670\u20132678. https:\/\/doi.org\/10.1128\/aac.00776-10","journal-title":"Antimicrob Agents Chemother"},{"key":"4850_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2021.107734","volume":"49","author":"M Cendra","year":"2021","unstructured":"Cendra M, Torrents E (2021) Pseudomonas aeruginosa biofilms and their partners in crime. Biotechnol Adv 49:107734. https:\/\/doi.org\/10.1016\/j.biotechadv.2021.107734","journal-title":"Biotechnol Adv"},{"issue":"6","key":"4850_CR24","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1111\/1462-2920.15784","volume":"24","author":"J Chadha","year":"2022","unstructured":"Chadha J, Harjai K, Chhibber S (2022) Revisiting the virulence hallmarks of Pseudomonas aeruginosa: a chronicle through the perspective of quorum sensing. Environ Microbiol 24(6):2630\u20132656","journal-title":"Environ Microbiol"},{"key":"4850_CR25","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3389\/fmicb.2015.01173","volume":"6","author":"KG Chan","year":"2015","unstructured":"Chan KG, Liu YC, Chang CY (2015) Inhibiting N-acyl-homoserine lactone synthesis and quenching Pseudomonas quinolone quorum sensing to attenuate virulence. Front Microbiol 6:1173. https:\/\/doi.org\/10.3389\/fmicb.2015.01173","journal-title":"Front Microbiol"},{"issue":"1","key":"4850_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04204-9","volume":"26","author":"J Chastre","year":"2022","unstructured":"Chastre J, Fran\u00e7ois B, Bourgeois M, Komnos A, Ferrer R, Rahav G, De Schryver N, Lepape A, Koksal I, Luyt CE, S\u00e1nchez-Garc\u00eda M, Torres A, Eggimann P, Koulenti D, Holland TL, Ali O, Shoemaker K, Ren P, Sauser J, Ruzin A, Tabor DE, Akhgar A, Wu Y, Jiang Y, DiGiandomenico A, Colbert S, Vandamme D, Coenjaerts F, Malhotra-Kumar S, Timbermont L, Oliver A, Barraud O, Bellamy T, Bonten M, Goossens H, Reisner C, Esser MT, Joannidis M, Klimscha W, De Waele E, Devriendt J, Huberlant V, Depuydt P, Van Boxstael S, Peric M, Kopic J, Hanauer M, Hruby T, Sramek V, Svoboda P, Vymazal T, Novacek M, Annane D, Mira J-P, Souweine B, Dequin P-F, Meziani F, Stephan F, Nseir S, Gibot S, Schwebel C, Plantefeve G, Diehl J-L, Richard C, Lamer C, Klouche K, Jaber S, Zakynthinos E, Filntisis G, Zakynthinos S, Koutsoukou A, Saroglou G, Nikolaou C, Vlachogianni G, Pnevmatikos I, Mandragos K, Kremer I, Rozgonyi ZD, Marjanek Z, Martin-Loeches I, Singer P, Van Heerden V, Carmeli Y, Povoa P, Seoane AA, Moura P, Gonzalez F, Ramirez P, Marti AT, Roca RF, Oteiza L, Escudero D, Piacentini E, Vera P, Tamayo L, Gallego MAG, Canas BS, Figueira I, Leon R, Korten V, Akova M, Wyncoll D, Whitehouse T, Hopkins P, Sim M, Golan Y, Zervos M, Vazquez J, Cherabuddi K, Smulian G, Rouphael N, Welker J, Sims M, Van Duin D, McCarthy T, Polk C, Jafri HS (2022) Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial. Crit Care 26(1):355. https:\/\/doi.org\/10.1186\/s13054-022-04204-9","journal-title":"Crit Care"},{"issue":"1","key":"4850_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-020-00389-5","volume":"19","author":"Z Chegini","year":"2020","unstructured":"Chegini Z, Khoshbayan A, Taati Moghadam M, Farahani I, Jazireian P, Shariati A (2020) Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review. Ann Clin Microbiol Antimicrob 19(1):45. https:\/\/doi.org\/10.1186\/s12941-020-00389-5","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"4850_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02764-21","author":"J Chen","year":"2022","unstructured":"Chen J, Lu Y, Ye F, Zhang H, Zhou Y, Li J, Wu Q, Xu X, Wu Q, Wei B, Zhang H, Wang H (2022) A small-molecule inhibitor of the anthranilyl-CoA synthetase PqsA for the treatment of multidrug-resistant Pseudomonas aeruginosa. Microbiol Spectr. https:\/\/doi.org\/10.1128\/spectrum.02764-21","journal-title":"Microbiol Spectr"},{"issue":"4","key":"4850_CR29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/apm.12673","volume":"125","author":"O Ciofu","year":"2017","unstructured":"Ciofu O, Rojo-Molinero E, Maci\u00e0 MD, Oliver A (2017) Antibiotic treatment of biofilm infections. APMIS 125(4):304\u2013319. https:\/\/doi.org\/10.1111\/apm.12673","journal-title":"APMIS"},{"issue":"12","key":"4850_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10121482","volume":"10","author":"A Cruz","year":"2021","unstructured":"Cruz A, Condinho M, Carvalho B, Arraiano CM, Pobre V, Pinto SN (2021) The two weapons against bacterial biofilms: detection and treatment. Antibiotics 10(12):1482","journal-title":"Antibiotics"},{"issue":"1","key":"4850_CR31","doi-asserted-by":"publisher","first-page":"2415598","DOI":"10.1080\/19420889.2024.2415598","volume":"17","author":"S Cui","year":"2024","unstructured":"Cui S, Kim E (2024) Quorum sensing and antibiotic resistance in polymicrobial infections. Commun Integr Biol 17(1):2415598. https:\/\/doi.org\/10.1080\/19420889.2024.2415598","journal-title":"Commun Integr Biol"},{"key":"4850_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10091187","author":"WS da Cruz Nizer","year":"2021","unstructured":"da Cruz Nizer WS, Inkovskiy V, Versey Z, Strempel N, Cassol E, Overhage J (2021) Oxidative stress response in Pseudomonas aeruginosa. Pathogens. https:\/\/doi.org\/10.3390\/pathogens10091187","journal-title":"Pathogens"},{"issue":"4","key":"4850_CR33","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3390\/molecules27041169","volume":"27","author":"T Das","year":"2022","unstructured":"Das T, Sabir S, Chen R, Farrell J, Kriel FH, Whiteley GS, Glasbey TO, Manos J, Willcox MDP, Kumar N (2022) Halogenated dihydropyrrol-2-one molecules inhibit pyocyanin biosynthesis by blocking the pseudomonas quinolone signaling system. Molecules 27(4):1169. https:\/\/www.mdpi.com\/1420-3049\/27\/4\/1169","journal-title":"Molecules"},{"issue":"5","key":"4850_CR34","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1007\/s12010-022-04280-1","volume":"195","author":"S Das","year":"2023","unstructured":"Das S, Paul P, Dastidar DG, Chakraborty P, Chatterjee S, Sarkar S, Maiti D, Tribedi P (2023) Piperine exhibits potential antibiofilm activity against Pseudomonas aeruginosa by accumulating reactive oxygen Species, affecting cell surface hydrophobicity and quorum sensing. Appl Biochem Biotechnol 195(5):3229\u20133256. https:\/\/doi.org\/10.1007\/s12010-022-04280-1","journal-title":"Appl Biochem Biotechnol"},{"key":"4850_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13080688","author":"A David","year":"2024","unstructured":"David A, Tahrioui A, Tareau AS, Forge A, Gonzalez M, Bouffartigues E, Lesouhaitier O, Chevalier S (2024) Pseudomonas aeruginosa biofilm lifecycle: involvement of mechanical constraints and timeline of matrix production. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics13080688","journal-title":"Antibiotics"},{"key":"4850_CR36","doi-asserted-by":"publisher","unstructured":"Dehari D, Chaudhuri A, Kumar DN, Agrawal AK (2024) Non-Traditional Antibacterial Therapeutic: Focus on Safety, Manufacturing, and Regulatory Dynamics. In: Gangwar M, Nath G (eds) Emerging Paradigms for Antibiotic-Resistant Infections: Beyond the Pill. Springer Nature Singapore, pp 787\u2013810. https:\/\/doi.org\/10.1007\/978-981-97-5272-0_37","DOI":"10.1007\/978-981-97-5272-0_37"},{"issue":"2","key":"4850_CR37","doi-asserted-by":"publisher","first-page":"262","DOI":"10.18683\/germs.2022.1328","volume":"12","author":"R Dehbanipour","year":"2022","unstructured":"Dehbanipour R, Ghalavand Z (2022) Anti-virulence therapeutic strategies against bacterial infections: recent advances. Germs 12(2):262\u2013275. https:\/\/doi.org\/10.18683\/germs.2022.1328","journal-title":"Germs"},{"key":"4850_CR38","doi-asserted-by":"publisher","first-page":"e19725","DOI":"10.7717\/peerj.19725","volume":"13","author":"M Diaz-Guerrero","year":"2025","unstructured":"Diaz-Guerrero M, L\u00f3pez-J\u00e1come LE, Franco-Cendejas R, Coria-Jim\u00e9nez R, Mart\u00ednez-Zavaleta MG, Gonz\u00e1lez-Pedrajo B, Huelgas-M\u00e9ndez D, Garc\u00eda-Contreras R (2025) Curcumin inhibits type III secretion of Pseudomonas aeruginosa. PeerJ 13:e19725. https:\/\/doi.org\/10.7717\/peerj.19725","journal-title":"PeerJ"},{"issue":"7","key":"4850_CR39","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrd.2017.23","volume":"16","author":"SW Dickey","year":"2017","unstructured":"Dickey SW, Cheung GYC, Otto M (2017) Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance. Nat Rev Drug Discov 16(7):457\u2013471. https:\/\/doi.org\/10.1038\/nrd.2017.23","journal-title":"Nat Rev Drug Discov"},{"key":"4850_CR40","doi-asserted-by":"publisher","first-page":"106129","DOI":"10.1016\/j.micpath.2023.106129","volume":"180","author":"ATL dos Santos","year":"2023","unstructured":"dos Santos ATL, de Ara\u00fajo-Neto JB, Costa da Silva MM, Paulino da Silva ME, Carneiro JNP, Fonseca VJA, Coutinho HDM, Bandeira PN, dos Santos HS, da Silva Mendes FR, Sales DL, Morais-Braga MFB (2023) Synthesis of Chalcones and their antimicrobial and drug potentiating activities. Microb Pathog 180:106129. https:\/\/doi.org\/10.1016\/j.micpath.2023.106129","journal-title":"Microb Pathog"},{"key":"4850_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2147\/idr.S287792","volume":"14","author":"IA Dutescu","year":"2021","unstructured":"Dutescu IA, Hillier SA (2021) Encouraging the development of new antibiotics: are financial incentives the right way forward? A systematic review and case study. Infect Drug Resist 14:415\u2013434. https:\/\/doi.org\/10.2147\/idr.S287792","journal-title":"Infect Drug Resist"},{"issue":"1","key":"4850_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-024-03707-5","volume":"24","author":"G Elahi","year":"2024","unstructured":"Elahi G, Goli HR, Shafiei M, Nikbin VS, Gholami M (2024) Antimicrobial resistance, virulence gene profiling, and genetic diversity of multidrug-resistant Pseudomonas aeruginosa isolates in Mazandaran, Iran. BMC Microbiol 24(1):546. https:\/\/doi.org\/10.1186\/s12866-024-03707-5","journal-title":"BMC Microbiol"},{"key":"4850_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1374466","author":"A Elfadadny","year":"2024","unstructured":"Elfadadny A, Ragab RF, AlHarbi M, Badshah F, Ib\u00e1\u00f1ez-Arancibia E, Farag A, Hendawy AO, De los R\u00edos-Escalante PR, Aboubakr M, Zakai SA, Nageeb WM (2024) Antimicrobial resistance of <Emphasis Type=\"Italic\">Pseudomonas aeruginosa<\/Emphasis>: navigating clinical impacts, current resistance trends, and innovations in breaking therapies. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2024.1374466","journal-title":"Front Microbiol"},{"issue":"3","key":"4850_CR44","doi-asserted-by":"publisher","DOI":"10.1099\/acmi.0.000211","volume":"3","author":"AA Elnegery","year":"2021","unstructured":"Elnegery AA, Mowafy WK, Zahra TA, Abou El-Khier NT (2021) Study of quorum-sensing LasR and RhlR genes and their dependent virulence factors in Pseudomonas aeruginosa isolates from infected burn wounds. Access Microbiol 3(3):000211. https:\/\/doi.org\/10.1099\/acmi.0.000211","journal-title":"Access Microbiol"},{"key":"4850_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioflm.2023.100129","volume":"5","author":"M Fern\u00e1ndez-Bill\u00f3n","year":"2023","unstructured":"Fern\u00e1ndez-Bill\u00f3n M, Llamb\u00edas-Cabot AE, Jordana-Lluch E, Oliver A, Maci\u00e0 MD (2023) Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms. Biofilm 5:100129. https:\/\/doi.org\/10.1016\/j.bioflm.2023.100129","journal-title":"Biofilm"},{"key":"4850_CR46","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jcis.2023.04.184","volume":"646","author":"G Ferreres","year":"2023","unstructured":"Ferreres G, Ivanova K, Torrent-Burgu\u00e9s J, Tzanov T (2023) Multimodal silver-chitosan-acylase nanoparticles inhibit bacterial growth and biofilm formation by Gram-negative Pseudomonas aeruginosa bacterium. J Colloid Interface Sci 646:576\u2013586. https:\/\/doi.org\/10.1016\/j.jcis.2023.04.184","journal-title":"J Colloid Interface Sci"},{"issue":"3","key":"4850_CR47","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1128\/MMBR.00082-15","volume":"80","author":"M Flores-D\u00edaz","year":"2016","unstructured":"Flores-D\u00edaz M, Monturiol-Gross L, Naylor C, Alape-Gir\u00f3n A, Flieger A (2016) Bacterial sphingomyelinases and phospholipases as virulence factors. Microbiol Mol Biol Rev 80(3):597\u2013628","journal-title":"Microbiol Mol Biol Rev"},{"key":"4850_CR48","doi-asserted-by":"publisher","unstructured":"Fu J, Zhang Y, Lin S, Zhang W, Shu G, Lin J, Li H, Xu F, Tang H, Peng G, Zhao L, Chen S, Fu H (2021) Strategies for interfering with bacterial early stage biofilms . Frontiers in microbiology. 12\u20132021. https:\/\/doi.org\/10.3389\/fmicb.2021.675843","DOI":"10.3389\/fmicb.2021.675843"},{"issue":"14","key":"4850_CR49","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1128\/jb.00363-10","volume":"192","author":"EL Fuchs","year":"2010","unstructured":"Fuchs EL, Brutinel ED, Jones AK, Fulcher NB, Urbanowski ML, Yahr TL, Wolfgang MC (2010) The Pseudomonas aeruginosa Vfr regulator controls global virulence factor expression through cyclic AMP-dependent and -independent mechanisms. J Bacteriol 192(14):3553\u20133564. https:\/\/doi.org\/10.1128\/jb.00363-10","journal-title":"J Bacteriol"},{"key":"4850_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e02192","author":"G Gebreyohannes","year":"2019","unstructured":"Gebreyohannes G, Nyerere A, Bii C, Sbhatu DB (2019) Challenges of intervention, treatment, and antibiotic resistance of biofilm-forming microorganisms. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2019.e02192","journal-title":"Heliyon"},{"key":"4850_CR51","doi-asserted-by":"publisher","DOI":"10.2147\/idr.s403441","author":"SM Ghanem","year":"2023","unstructured":"Ghanem SM, Abd El-Baky RM, Abourehab MA, Fadl GF, Gamil NG (2023) Prevalence of quorum sensing and virulence factor genes among <Emphasis Type=\"Italic\">Pseudomonas aeruginosa<\/Emphasis> isolated from patients suffering from different infections and their association with antimicrobial resistance. Infect Drug Resist. https:\/\/doi.org\/10.2147\/idr.s403441","journal-title":"Infect Drug Resist"},{"issue":"5","key":"4850_CR52","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1080\/07391102.2023.2203258","volume":"42","author":"A Gholami","year":"2024","unstructured":"Gholami A, Minai-Tehrani D, Farewell A, Eriksson LA (2024) Discovery of novel inhibitors for Pseudomonas aeruginosa lipase enzyme from in silico and in vitro studies. J Biomol Struct Dyn 42(5):2197\u20132210","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"4850_CR53","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/cbdd.12478","volume":"85","author":"EE Gill","year":"2015","unstructured":"Gill EE, Franco OL, Hancock RE (2015) Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens. Chem Biol Drug Des 85(1):56\u201378. https:\/\/doi.org\/10.1111\/cbdd.12478","journal-title":"Chem Biol Drug Des"},{"key":"4850_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1557664","volume":"16","author":"A Grace","year":"2025","unstructured":"Grace A, Sahu R, Owen DR, Dennis VA (2025) Host-mimicking conditions promote Pseudomonas aeruginosa PA14 virulence gene expression. Front Microbiol 16:1557664. https:\/\/doi.org\/10.3389\/fmicb.2025.1557664","journal-title":"Front Microbiol"},{"key":"4850_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.microb.2025.100436","volume":"8","author":"O Grari","year":"2025","unstructured":"Grari O, Ezrari S, El Yandouzi I, Benaissa E, Ben Lahlou Y, Lahmer M, Saddari A, Elouennass M, Maleb A (2025) A comprehensive review on biofilm-associated infections: mechanisms, diagnostic challenges, and innovative therapeutic strategies. The Microbe 8:100436. https:\/\/doi.org\/10.1016\/j.microb.2025.100436","journal-title":"The Microbe"},{"key":"4850_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15112582","author":"Y Guo","year":"2023","unstructured":"Guo Y, Mao Z, Ran F, Sun J, Zhang J, Chai G, Wang J (2023) Nanotechnology-based drug delivery systems to control bacterial-biofilm-associated lung infections. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15112582","journal-title":"Pharmaceutics"},{"key":"4850_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.microb.2025.100233","volume":"6","author":"N Gupta","year":"2025","unstructured":"Gupta N, Chauhan K, Singh G, Chaudhary S, Rathore JS (2025) Decoding antibiotic resistance in Pseudomonas aeruginosa: embracing innovative therapies beyond conventional antibiotics. The Microbe 6:100233. https:\/\/doi.org\/10.1016\/j.microb.2025.100233","journal-title":"The Microbe"},{"issue":"10","key":"4850_CR58","doi-asserted-by":"publisher","first-page":"5818","DOI":"10.1128\/aac.03170-14","volume":"58","author":"MB Habash","year":"2014","unstructured":"Habash MB, Park AJ, Vis EC, Harris RJ, Khursigara CM (2014) Synergy of silver nanoparticles and aztreonam against Pseudomonas aeruginosa PAO1 biofilms. Antimicrob Agents Chemother 58(10):5818\u20135830. https:\/\/doi.org\/10.1128\/aac.03170-14","journal-title":"Antimicrob Agents Chemother"},{"key":"4850_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.microb.2024.100078","volume":"3","author":"A Haidar","year":"2024","unstructured":"Haidar A, Muazzam A, Nadeem A, Atique R, Saeed HA, Naveed A, Sharif J, Perveen A, Fatima HR, Samad A (2024) Biofilm formation and antibiotic resistance in Pseudomonas aeruginosa. The Microbe 3:100078. https:\/\/doi.org\/10.1016\/j.microb.2024.100078","journal-title":"The Microbe"},{"issue":"3","key":"4850_CR60","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/femsre\/fux010","volume":"41","author":"CW Hall","year":"2017","unstructured":"Hall CW, Mah T-F (2017) Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol Rev 41(3):276\u2013301. https:\/\/doi.org\/10.1093\/femsre\/fux010","journal-title":"FEMS Microbiol Rev"},{"key":"4850_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26195854","author":"Q Han","year":"2021","unstructured":"Han Q, Yan X, Zhang R, Wang G, Zhang Y (2021) Juglone inactivates <Emphasis Type=\"Italic\">Pseudomonas aeruginosa<\/Emphasis> through cell membrane damage, biofilm blockage, and inhibition of gene expression. Molecules. https:\/\/doi.org\/10.3390\/molecules26195854","journal-title":"Molecules"},{"key":"4850_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094946","author":"S Hao","year":"2021","unstructured":"Hao S, Yang D, Zhao L, Shi F, Ye G, Fu H, Lin J, Guo H, He R, Li J, Chen H, Khan MF, Li Y, Tang H (2021) EGCG-mediated potential inhibition of biofilm development and quorum sensing in <Emphasis Type=\"Italic\">Pseudomonas aeruginosa<\/Emphasis>. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22094946","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4850_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64416-7","volume":"14","author":"J Hemmati","year":"2024","unstructured":"Hemmati J, Chiani M, Chegini Z, Seifalian A, Arabestani MR (2024) Surface modified niosomal quercetin with cationic lipid: an appropriate drug delivery system against Pseudomonas aeruginosa infections. Sci Rep 14(1):13362. https:\/\/doi.org\/10.1038\/s41598-024-64416-7","journal-title":"Sci Rep"},{"issue":"15","key":"4850_CR64","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1093\/emboj\/cdg366","volume":"22","author":"M Hentzer","year":"2003","unstructured":"Hentzer M, Wu H, Andersen JB, Riedel K, Rasmussen TB, Bagge N, Kumar N, Schembri MA, Song Z, Kristoffersen P, Manefield M, Costerton JW, Molin S, Eberl L, Steinberg P, Kjelleberg S, H\u00f8iby N, Givskov M (2003) Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. Embo J 22(15):3803\u20133815. https:\/\/doi.org\/10.1093\/emboj\/cdg366","journal-title":"Embo J"},{"issue":"6","key":"4850_CR65","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1080\/1040841x.2023.2285995","volume":"50","author":"TM Hibbert","year":"2024","unstructured":"Hibbert TM, Whiteley M, Renshaw SA, Neill DR, Fothergill JL (2024) Emerging strategies to target virulence in Pseudomonas aeruginosa respiratory infections. Crit Rev Microbiol 50(6):1037\u20131052. https:\/\/doi.org\/10.1080\/1040841x.2023.2285995","journal-title":"Crit Rev Microbiol"},{"key":"4850_CR66","doi-asserted-by":"crossref","unstructured":"Hinkel LA, Wargo MJ (2020) Participation of bacterial lipases, sphingomyelinases, and phospholipases in gram-negative bacterial pathogenesis. Health Consequences of Microbial Interactions with Hydrocarbons, Oils, and Lipids, pp 181\u2013203","DOI":"10.1007\/978-3-030-15147-8_15"},{"key":"4850_CR67","doi-asserted-by":"publisher","first-page":"126719","DOI":"10.1016\/j.micres.2021.126719","volume":"246","author":"G Horna","year":"2021","unstructured":"Horna G, Ruiz J (2021) Type 3 secretion system of Pseudomonas aeruginosa. Microbiol Res 246:126719. https:\/\/doi.org\/10.1016\/j.micres.2021.126719","journal-title":"Microbiol Res"},{"key":"4850_CR68","doi-asserted-by":"publisher","first-page":"1117844","DOI":"10.3389\/fcimb.2023.1117844","volume":"13","author":"AM Horspool","year":"2023","unstructured":"Horspool AM, Sen-Kilic E, Malkowski AC, Breslow SL, Mateu-Borras M, Hudson MS, Nunley MA, Elliott S, Ray K, Snyder GA, Miller SJ, Kang J, Blackwood CB, Weaver KL, Witt WT, Huckaby AB, Pyles GM, Clark T, Qatarneh A, Barbier S, M (2023) Development of an anti-Pseudomonas aeruginosa therapeutic monoclonal antibody WVDC-5244. Front Cell Infect Microbiol 13:1117844. https:\/\/doi.org\/10.3389\/fcimb.2023.1117844","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"4850_CR69","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3390\/microorganisms13040913","volume":"13","author":"M Hu","year":"2025","unstructured":"Hu M, Chua SL (2025) Antibiotic-resistant Pseudomonas aeruginosa: current challenges and emerging alternative therapies. Microorganisms 13(4):913 https:\/\/www.mdpi.com\/2076-2607\/13\/4\/913","journal-title":"Microorganisms"},{"issue":"4","key":"4850_CR70","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1111\/jam.15601","volume":"133","author":"X-H Huang","year":"2022","unstructured":"Huang X-H, She M-T, Zhang Y-H, Liu Y-F, Zhong D-X, Zhang Y-H, Zheng J-X, Sun N, Wong W-L, Lu Y-J (2022) Novel quinoline-based derivatives as the PqsR inhibitor against Pseudomonas aeruginosa PAO1. J Appl Microbiol 133(4):2167\u20132181. https:\/\/doi.org\/10.1111\/jam.15601","journal-title":"J Appl Microbiol"},{"issue":"2","key":"4850_CR71","doi-asserted-by":"publisher","first-page":"e0024921","DOI":"10.1128\/Spectrum.00249-21","volume":"9","author":"HJ Hwang","year":"2021","unstructured":"Hwang HJ, Choi H, Hong S, Moon HR, Lee JH (2021) Antipathogenic compounds that are effective at very low concentrations and have both antibiofilm and antivirulence effects against Pseudomonas aeruginosa. Microbiol Spectr 9(2):e0024921. https:\/\/doi.org\/10.1128\/Spectrum.00249-21","journal-title":"Microbiol Spectr"},{"key":"4850_CR72","doi-asserted-by":"publisher","first-page":"107661","DOI":"10.1016\/j.rmed.2024.107661","volume":"227","author":"N Islam","year":"2024","unstructured":"Islam N, Reid D (2024) Inhaled antibiotics: A promising drug delivery strategies for efficient treatment of lower respiratory tract infections (LRTIs) associated with antibiotic resistant biofilm-dwelling and intracellular bacterial pathogens. Respir Med 227:107661. https:\/\/doi.org\/10.1016\/j.rmed.2024.107661","journal-title":"Respir Med"},{"key":"4850_CR73","doi-asserted-by":"publisher","first-page":"100529","DOI":"10.1016\/j.rsurfi.2025.100529","volume":"19","author":"S Islam","year":"2025","unstructured":"Islam S, Ahmed MMS, Islam MA, Hossain N, Chowdhury MA (2025) Advances in nanoparticles in targeted drug delivery\u2013A review. Results Surf Interfaces 19:100529. https:\/\/doi.org\/10.1016\/j.rsurfi.2025.100529","journal-title":"Results Surf Interfaces"},{"key":"4850_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207658","author":"AS Joshi","year":"2020","unstructured":"Joshi AS, Singh P, Mijakovic I (2020) Interactions of gold and silver nanoparticles with bacterial biofilms: molecular interactions behind inhibition and resistance. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21207658","journal-title":"Int J Mol Sci"},{"key":"4850_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063128","author":"I Jurado-Mart\u00edn","year":"2021","unstructured":"Jurado-Mart\u00edn I, Sainz-Mej\u00edas M, McClean S (2021) <Emphasis Type=\"Italic\">Pseudomonas aeruginosa<\/Emphasis>: an audacious pathogen with an adaptable arsenal of virulence factors. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22063128","journal-title":"Int J Mol Sci"},{"key":"4850_CR76","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.lfs.2018.03.013","volume":"199","author":"M Kalia","year":"2018","unstructured":"Kalia M, Yadav VK, Singh PK, Sharma D, Narvi SS, Agarwal V (2018) Exploring the impact of parthenolide as anti-quorum sensing and anti-biofilm agent against Pseudomonas aeruginosa. Life Sci 199:96\u2013103. https:\/\/doi.org\/10.1016\/j.lfs.2018.03.013","journal-title":"Life Sci"},{"issue":"5","key":"4850_CR77","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1046\/j.1365-2958.1998.01121.x","volume":"30","author":"S Kamath","year":"1998","unstructured":"Kamath S, Kapatral V, Chakrabarty AM (1998) Cellular function of elastase in Pseudomonas aeruginosa: role in the cleavage of nucleoside diphosphate kinase and in alginate synthesis. Mol Microbiol 30(5):933\u2013941. https:\/\/doi.org\/10.1046\/j.1365-2958.1998.01121.x","journal-title":"Mol Microbiol"},{"key":"4850_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.134533","volume":"278","author":"F Khan","year":"2024","unstructured":"Khan F (2024) Multifaceted strategies for alleviating Pseudomonas aeruginosa infection by targeting protease activity: natural and synthetic molecules. Int J Biol Macromol 278:134533. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.134533","journal-title":"Int J Biol Macromol"},{"key":"4850_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/md17040208","author":"F Khan","year":"2019","unstructured":"Khan F, Manivasagan P, Lee JW, Pham DTN, Oh J, Kim YM (2019) Fucoidan-stabilized gold nanoparticle-mediated biofilm inhibition, attenuation of virulence and motility properties in <Emphasis Type=\"Italic\">Pseudomonas aeruginosa<\/Emphasis> PAO1. Mar Drugs. https:\/\/doi.org\/10.3390\/md17040208","journal-title":"Mar Drugs"},{"key":"4850_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10071100","author":"M Killough","year":"2022","unstructured":"Killough M, Rodgers AM, Ingram RJ (2022) <Emphasis Type=\"Italic\">Pseudomonas aeruginosa<\/Emphasis>: recent advances in vaccine development. Vaccines. https:\/\/doi.org\/10.3390\/vaccines10071100","journal-title":"Vaccines"},{"issue":"9","key":"4850_CR81","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1099\/mic.0.26276-0","volume":"149","author":"E-J Kim","year":"2003","unstructured":"Kim E-J, Sabra W, Zeng A-P (2003) Iron deficiency leads to inhibition of oxygen transfer and enhanced formation of virulence factors in cultures of Pseudomonas aeruginosa PAO1. Microbiology 149(9):2627\u20132634. https:\/\/doi.org\/10.1099\/mic.0.26276-0","journal-title":"Microbiology"},{"key":"4850_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/srep08656","volume":"5","author":"HS Kim","year":"2015","unstructured":"Kim HS, Lee SH, Byun Y, Park HD (2015) 6-gingerol reduces Pseudomonas aeruginosa biofilm formation and virulence via quorum sensing inhibition. Sci Rep 5:8656. https:\/\/doi.org\/10.1038\/srep08656","journal-title":"Sci Rep"},{"key":"4850_CR83","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.fitote.2015.02.002","volume":"102","author":"L Kumar","year":"2015","unstructured":"Kumar L, Chhibber S, Kumar R, Kumar M, Harjai K (2015) Zingerone silences quorum sensing and attenuates virulence of Pseudomonas aeruginosa. Fitoterapia 102:84\u201395. https:\/\/doi.org\/10.1016\/j.fitote.2015.02.002","journal-title":"Fitoterapia"},{"key":"4850_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113589","volume":"381","author":"J Lan","year":"2025","unstructured":"Lan J, Zou J, Xin H, Sun J, Han T, Sun M, Niu M (2025) Nanomedicines as disruptors or inhibitors of biofilms: opportunities in addressing antimicrobial resistance. J Control Release 381:113589. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113589","journal-title":"J Control Release"},{"key":"4850_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104429","author":"WYV Lau","year":"2023","unstructured":"Lau WYV, Taylor PK, Brinkman FSL, Lee AHY (2023) Pathogen-associated gene discovery workflows for novel antivirulence therapeutic development. eBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104429","journal-title":"eBioMedicine"},{"key":"4850_CR86","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02565-17","author":"HN Le","year":"2018","unstructured":"Le HN, Quetz JS, Tran VG, Le VTM, Aguiar-Alves F, Pinheiro MG, Cheng L, Yu L, Sellman BR, Stover CK, DiGiandomenico A, Diep BA (2018) MEDI3902 correlates of protection against severe <Emphasis Type=\"Italic\">Pseudomonas aeruginosa<\/Emphasis> pneumonia in a rabbit acute pneumonia model. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/aac.02565-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"4850_CR87","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nchembio.1225","volume":"9","author":"J Lee","year":"2013","unstructured":"Lee J, Wu J, Deng Y, Wang J, Wang C, Wang J, Chang C, Dong Y, Williams P, Zhang L-H (2013) A cell-cell communication signal integrates quorum sensing and stress response. Nat Chem Biol 9(5):339\u2013343. https:\/\/doi.org\/10.1038\/nchembio.1225","journal-title":"Nat Chem Biol"},{"key":"4850_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118090","volume":"187","author":"MM Leit\u00e3o","year":"2025","unstructured":"Leit\u00e3o MM, Gon\u00e7alves ASC, Sousa SF, Borges F, Sim\u00f5es M, Borges A (2025) Two cinnamic acid derivatives as inhibitors of Pseudomonas aeruginosa las and pqs quorum-sensing systems: impact on biofilm formation and virulence factors. Biomed Pharmacother 187:118090. https:\/\/doi.org\/10.1016\/j.biopha.2025.118090","journal-title":"Biomed Pharmacother"},{"key":"4850_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11060794","author":"A Le\u00f3n-Buitimea","year":"2022","unstructured":"Le\u00f3n-Buitimea A, Garza-C\u00e1rdenas CR, Rom\u00e1n-Garc\u00eda MF, Ram\u00edrez-D\u00edaz CA, Ulloa-Ram\u00edrez M, Morones-Ram\u00edrez JR (2022) Nanomaterials-based combinatorial therapy as a strategy to combat antibiotic resistance. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics11060794","journal-title":"Antibiotics"},{"key":"4850_CR90","doi-asserted-by":"publisher","unstructured":"Liao C, Huang X, Wang Q, Yao D, Lu W (2022) Virulence factors of Pseudomonas aeruginosa and antivirulence strategies to combat its drug resistance . Frontiers in cellular and infection microbiology. 12\u20132022. https:\/\/doi.org\/10.3389\/fcimb.2022.926758","DOI":"10.3389\/fcimb.2022.926758"},{"issue":"1","key":"4850_CR91","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1021\/acs.jmedchem.1c01781","volume":"65","author":"J Liu","year":"2022","unstructured":"Liu J, Hou J-S, Chang Y-Q, Peng L-J, Zhang X-Y, Miao Z-Y, Sun P-H, Lin J, Chen W-M (2022) New Pqs quorum sensing system inhibitor as an antibacterial synergist against multidrug-resistant Pseudomonas aeruginosa. J Med Chem 65(1):688\u2013709. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c01781","journal-title":"J Med Chem"},{"issue":"1","key":"4850_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-41333-9","volume":"13","author":"A Llanos","year":"2023","unstructured":"Llanos A, Achard P, Bousquet J, Lozano C, Zalacain M, Sable C, Revillet H, Murris M, Mittaine M, Lemonnier M, Everett M (2023) Higher levels of Pseudomonas aeruginosa LasB elastase expression are associated with early-stage infection in cystic fibrosis patients. Sci Rep 13(1):14208. https:\/\/doi.org\/10.1038\/s41598-023-41333-9","journal-title":"Sci Rep"},{"issue":"1","key":"4850_CR93","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1164\/rccm.202308-1403OC","volume":"210","author":"MB Long","year":"2024","unstructured":"Long MB, Gilmour A, Kehl M, Tabor DE, Keller AE, Warrener P, Gopalakrishnan V, Rosengren S, Crichton ML, McIntosh E, Giam YH, Keir HR, Brailsford W, Hughes R, Belvisi MG, Sellman BR, DiGiandomenico A, Chalmers JD (2024) A bispecific monoclonal antibody targeting Psl and PcrV enhances neutrophil-mediated killing of Pseudomonas aeruginosa in patients with bronchiectasis. Am J Respir Crit Care Med 210(1):35\u201346. https:\/\/doi.org\/10.1164\/rccm.202308-1403OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"4850_CR94","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1021\/acsptsci.3c00354","volume":"7","author":"Y Ma","year":"2024","unstructured":"Ma Y, Tang WS, Liu SY, Khoo BL, Chua SL (2024) Juglone as a natural quorum sensing inhibitor against Pseudomonas aeruginosa pqs-mediated virulence and biofilms. ACS Pharmacol Transl Sci 7(2):533\u2013543. https:\/\/doi.org\/10.1021\/acsptsci.3c00354","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"13","key":"4850_CR95","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1089\/ars.2014.5979","volume":"22","author":"A Manag\u00f2","year":"2015","unstructured":"Manag\u00f2 A, Becker KA, Carpinteiro A, Wilker B, Soddemann M, Seitz AP, Edwards MJ, Grassm\u00e9 H, Szab\u00f2 I, Gulbins E (2015) Pseudomonas aeruginosa pyocyanin induces neutrophil death via mitochondrial reactive oxygen species and mitochondrial acid sphingomyelinase. Antioxid Redox Signal 22(13):1097\u20131110. https:\/\/doi.org\/10.1089\/ars.2014.5979","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"4850_CR96","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1021\/acsinfecdis.3c00593","volume":"10","author":"DE Manson","year":"2024","unstructured":"Manson DE, Ananiev GE, Guo S, Ericksen SS, Santa EE, Blackwell HE (2024) Abiotic small molecule inhibitors and activators of the LasR quorum sensing receptor in Pseudomonas aeruginosa with potencies comparable or surpassing N-acyl homoserine lactones. ACS Infect Dis 10(4):1212\u20131221. https:\/\/doi.org\/10.1021\/acsinfecdis.3c00593","journal-title":"ACS Infect Dis"},{"key":"4850_CR97","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mib.2016.06.001","volume":"33","author":"D Maura","year":"2016","unstructured":"Maura D, Ballok AE, Rahme LG (2016) Considerations and caveats in anti-virulence drug development. Curr Opin Microbiol 33:41\u201346. https:\/\/doi.org\/10.1016\/j.mib.2016.06.001","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"4850_CR98","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s0378-1097(03)00849-8","volume":"230","author":"S McGrath","year":"2004","unstructured":"McGrath S, Wade DS, Pesci EC (2004) Dueling quorum sensing systems in Pseudomonas aeruginosa control the production of the Pseudomonas quinolone signal (PQS). FEMS Microbiol Lett 230(1):27\u201334. https:\/\/doi.org\/10.1016\/s0378-1097(03)00849-8","journal-title":"FEMS Microbiol Lett"},{"issue":"10","key":"4850_CR99","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1128\/jb.182.10.2702-2708.2000","volume":"182","author":"SL McKnight","year":"2000","unstructured":"McKnight SL, Iglewski BH, Pesci EC (2000) The Pseudomonas quinolone signal regulates Rhl quorum sensing in Pseudomonas aeruginosa. J Bacteriol 182(10):2702\u20132708. https:\/\/doi.org\/10.1128\/jb.182.10.2702-2708.2000","journal-title":"J Bacteriol"},{"issue":"33","key":"4850_CR100","doi-asserted-by":"publisher","first-page":"13333","DOI":"10.1039\/D4SC02703E","volume":"15","author":"O Metelkina","year":"2024","unstructured":"Metelkina O, Konstantinovi\u0107 J, Klein A, Shafiei R, Fares M, Alhayek A, Yahiaoui S, Elgaher WAM, Haupenthal J, Titz A, Hirsch AK H (2024) Dual inhibitors of Pseudomonas aeruginosa virulence factors LecA and LasB [10.1039\/D4SC02703E]. Chem Sci 15(33):13333\u201313342. https:\/\/doi.org\/10.1039\/D4SC02703E","journal-title":"Chem Sci"},{"issue":"3","key":"4850_CR101","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s11262-019-01660-4","volume":"55","author":"L Mi","year":"2019","unstructured":"Mi L, Liu Y, Wang C, He T, Gao S, Xing S, Huang Y, Fan H, Zhang X, Yu W, Mi Z, Tong Y, Bai C, Han F (2019) Identification of a lytic Pseudomonas aeruginosa phage depolymerase and its anti-biofilm effect and bactericidal contribution to serum. Virus Genes 55(3):394\u2013405. https:\/\/doi.org\/10.1007\/s11262-019-01660-4","journal-title":"Virus Genes"},{"key":"4850_CR102","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3389\/fmicb.2015.00963","volume":"6","author":"M Michalska","year":"2015","unstructured":"Michalska M, Wolf P (2015) Pseudomonas exotoxin A: optimized by evolution for effective killing. Front Microbiol 6:963. https:\/\/doi.org\/10.3389\/fmicb.2015.00963","journal-title":"Front Microbiol"},{"key":"4850_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26082189","author":"HB Mohammed","year":"2021","unstructured":"Mohammed HB, Rayyif SMI, Curutiu C, Birca AC, Oprea OC, Grumezescu AM, Ditu LM, Gheorghe I, Chifiriuc MC, Mihaescu G, Holban AM (2021) Eugenol-functionalized magnetite nanoparticles modulate virulence and persistence in <Emphasis Type=\"Italic\">Pseudomonas aeruginosa<\/Emphasis> clinical strains. Molecules. https:\/\/doi.org\/10.3390\/molecules26082189","journal-title":"Molecules"},{"issue":"4","key":"4850_CR104","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/antibiotics14040367","volume":"14","author":"M Moradi","year":"2025","unstructured":"Moradi M, Montazeri EA, Asl R, Pormohammad S, Farshadzadeh A, Dayer Z, D, Turner RJ (2025) In vitro and in vivo antibacterial and antibiofilm activity of zinc sulfate (ZnSO4) and carvacrol (CV) alone and in combination with antibiotics against pseudomonas aeruginosa. Antibiotics 14(4):367. https:\/\/www.mdpi.com\/2079-6382\/14\/4\/367","journal-title":"Antibiotics"},{"issue":"11","key":"4850_CR105","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1128\/aac.00665-06","volume":"50","author":"U M\u00fch","year":"2006","unstructured":"M\u00fch U, Schuster M, Heim R, Singh A, Olson ER, Greenberg EP (2006) Novel Pseudomonas aeruginosa quorum-sensing inhibitors identified in an ultra-high-throughput screen. Antimicrob Agents Chemother 50(11):3674\u20133679. https:\/\/doi.org\/10.1128\/aac.00665-06","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"4850_CR106","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3390\/antibiotics14060555","volume":"14","author":"M Mulat","year":"2025","unstructured":"Mulat M, Banicod RJS, Tabassum N, Javaid A, Karthikeyan A, Jeong G-J, Kim Y-M, Jung W-K, Khan F (2025) Multiple strategies for the application of medicinal plant-derived bioactive compounds in controlling microbial biofilm and virulence properties. Antibiotics 14(6):555. https:\/\/www.mdpi.com\/2079-6382\/14\/6\/555","journal-title":"Antibiotics"},{"key":"4850_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/ph16111615","author":"G Muteeb","year":"2023","unstructured":"Muteeb G, Rehman MT, Shahwan M, Aatif M (2023) Origin of antibiotics and antibiotic resistance, and their impacts on drug development: a narrative review. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph16111615","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"4850_CR108","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s11274-022-03337-x","volume":"38","author":"NG Naga","year":"2022","unstructured":"Naga NG, Zaki AA, El-Badan DE, Rateb HS, Ghanem KM, Shaaban MI (2022) Methoxyisoflavan derivative from Trigonella stellata inhibited quorum sensing and virulence factors of Pseudomonas aeruginosa. World J Microbiol Biotechnol 38(9):156. https:\/\/doi.org\/10.1007\/s11274-022-03337-x","journal-title":"World J Microbiol Biotechnol"},{"issue":"1","key":"4850_CR109","doi-asserted-by":"publisher","first-page":"17942","DOI":"10.1038\/s41598-023-44063-0","volume":"13","author":"NG Naga","year":"2023","unstructured":"Naga NG, Zaki AA, El-Badan DE, Rateb HS, Ghanem KM, Shaaban MI (2023) Inhibition of Pseudomonas aeruginosa quorum sensing by Methyl gallate from mangifera indica. Sci Rep 13(1):17942. https:\/\/doi.org\/10.1038\/s41598-023-44063-0","journal-title":"Sci Rep"},{"issue":"40","key":"4850_CR110","doi-asserted-by":"publisher","first-page":"31219","DOI":"10.1074\/jbc.M003903200","volume":"275","author":"M Nardini","year":"2000","unstructured":"Nardini M, Lang DA, Liebeton K, Jaeger K-E, Dijkstra BW (2000) Crystal structure of Pseudomonas aeruginosa lipase in the open conformation: THE PROTOTYPE FOR FAMILY I.1 OF BACTERIAL LIPASES*. J Biol Chem 275(40):31219\u201331225. https:\/\/doi.org\/10.1074\/jbc.M003903200","journal-title":"J Biol Chem"},{"key":"4850_CR111","doi-asserted-by":"publisher","unstructured":"Nickerson R, Thornton CS, Johnston B, Lee AHY, Cheng Z (2024) Pseudomonas aeruginosa in chronic lung disease: untangling the dysregulated host immune response. Frontiers in immunology. 15\u20132024. https:\/\/doi.org\/10.3389\/fimmu.2024.1405376","DOI":"10.3389\/fimmu.2024.1405376"},{"issue":"44","key":"4850_CR112","doi-asserted-by":"publisher","first-page":"17981","DOI":"10.1073\/pnas.1316981110","volume":"110","author":"CT O\u2019Loughlin","year":"2013","unstructured":"O\u2019Loughlin CT, Miller LC, Siryaporn A, Drescher K, Semmelhack MF, Bassler BL (2013) A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation. Proc Natl Acad Sci U S A 110(44):17981\u201317986. https:\/\/doi.org\/10.1073\/pnas.1316981110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4850_CR113","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1186\/s12879-024-10359-3","volume":"24","author":"MD Olana","year":"2024","unstructured":"Olana MD, Asrat D, Swedberg G (2024) Antimicrobial resistance profile, biofilm forming capacity and associated factors of multidrug resistance in Pseudomonas aeruginosa among patients admitted at Tikur Anbessa specialized hospital and Yekatit 12 hospital medical college in addis Ababa, Ethiopia. BMC Infect Dis 24(1):1472. https:\/\/doi.org\/10.1186\/s12879-024-10359-3","journal-title":"BMC Infect Dis"},{"issue":"8","key":"4850_CR114","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1128\/aac.49.8.3281-3288.2005","volume":"49","author":"E O\u0142dak","year":"2005","unstructured":"O\u0142dak E, Trafny EA (2005) Secretion of proteases by Pseudomonas aeruginosa biofilms exposed to Ciprofloxacin. Antimicrob Agents Chemother 49(8):3281\u20133288. https:\/\/doi.org\/10.1128\/aac.49.8.3281-3288.2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4850_CR115","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12866-025-04034-z","volume":"25","author":"RL Oliva","year":"2025","unstructured":"Oliva RL, Khadka UB, Camenzind T, Dyckmans J, Joergensen RG (2025) Constituent of extracellular polymeric substances (EPS) produced by a range of soil bacteria and fungi. BMC Microbiol 25(1):298. https:\/\/doi.org\/10.1186\/s12866-025-04034-z","journal-title":"BMC Microbiol"},{"key":"4850_CR116","doi-asserted-by":"publisher","first-page":"127656","DOI":"10.1016\/j.micres.2024.127656","volume":"282","author":"BA Omran","year":"2024","unstructured":"Omran BA, Tseng BS, Baek K-H (2024) Nanocomposites against Pseudomonas aeruginosa biofilms: recent advances, challenges, and future prospects. Microbiol Res 282:127656. https:\/\/doi.org\/10.1016\/j.micres.2024.127656","journal-title":"Microbiol Res"},{"issue":"7","key":"4850_CR117","first-page":"601","volume":"18","author":"C Palleria","year":"2013","unstructured":"Palleria C, Di Paolo A, Giofr\u00e8 C, Caglioti C, Leuzzi G, Siniscalchi A, De Sarro G, Gallelli L (2013) Pharmacokinetic drug-drug interaction and their implication in clinical management. J Res Med Sci 18(7):601\u2013610","journal-title":"J Res Med Sci"},{"key":"4850_CR118","unstructured":"Pan S (2024) Biofilm formation and virulence factor production in Pseudomonas aeruginosa are impacted by the Nitro-PTS, nutritional Cues, and a putative. Lipase Enzyme Oklahoma State University]"},{"key":"4850_CR119","doi-asserted-by":"publisher","unstructured":"Pan D, Wu H, Li J-J, Wang B, Jia A-Q (2024) Two cinnamoyl hydroxamates as potential quorum sensing inhibitors against Pseudomonas aeruginosa. Front Cell Infect Microbiol 14\u20132024. https:\/\/doi.org\/10.3389\/fcimb.2024.1424038","DOI":"10.3389\/fcimb.2024.1424038"},{"key":"4850_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2021.107871","volume":"54","author":"N Papon","year":"2022","unstructured":"Papon N, Copp BR, Courdavault V (2022) Marine drugs: biology, pipelines, current and future prospects for production. Biotechnol Adv 54:107871. https:\/\/doi.org\/10.1016\/j.biotechadv.2021.107871","journal-title":"Biotechnol Adv"},{"key":"4850_CR121","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.pmpp.2018.08.003","volume":"104","author":"A Pascoal","year":"2018","unstructured":"Pascoal A, Estevinho LM, Martins IM, Choupina AB (2018) Novel sources and functions of microbial lipases and their role in the infection mechanisms. Physiol Mol Plant Pathol 104:119\u2013126","journal-title":"Physiol Mol Plant Pathol"},{"issue":"12","key":"4850_CR122","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/s41374-020-00478-1","volume":"100","author":"ASB Prasad","year":"2020","unstructured":"Prasad ASB, Shruptha P, Prabhu V, Srujan C, Nayak UY, Anuradha CKR, Ramachandra L, Keerthana P, Joshi MB, Murali TS, Satyamoorthy K (2020) Pseudomonas aeruginosa virulence proteins pseudolysin and protease IV impede cutaneous wound healing. Lab Invest 100(12):1532\u20131550. https:\/\/doi.org\/10.1038\/s41374-020-00478-1","journal-title":"Lab Invest"},{"key":"4850_CR123","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fcimb.2017.00093","volume":"7","author":"BR Prateeksha, Singh","year":"2017","unstructured":"Prateeksha, Singh BR, Shoeb M, Sharma S, Naqvi AH, Gupta VK, Singh BN (2017) Scaffold of selenium nanovectors and honey phytochemicals for Inhibition of Pseudomonas aeruginosa quorum sensing and biofilm formation. Front Cell Infect Microbiol 7:93. https:\/\/doi.org\/10.3389\/fcimb.2017.00093","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"4850_CR124","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1080\/08927014.2021.1955250","volume":"37","author":"FA Qais","year":"2021","unstructured":"Qais FA, Khan MS, Ahmad I, Husain FM, Al-Kheraif AA, Arshad M, Alam P (2021) Plumbagin inhibits quorum sensing-regulated virulence and biofilms of Gram-negative bacteria: in vitro and in silico investigations. Biofouling 37(7):724\u2013739. https:\/\/doi.org\/10.1080\/08927014.2021.1955250","journal-title":"Biofouling"},{"issue":"1","key":"4850_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01056-1","volume":"7","author":"S Qin","year":"2022","unstructured":"Qin S, Xiao W, Zhou C, Pu Q, Deng X, Lan L, Liang H, Song X, Wu M (2022) Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduction and Targeted Therapy 7(1):199. https:\/\/doi.org\/10.1038\/s41392-022-01056-1","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"7","key":"4850_CR126","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s10529-018-2557-9","volume":"40","author":"J Rajkumari","year":"2018","unstructured":"Rajkumari J, Borkotoky S, Murali A, Suchiang K, Mohanty SK, Busi S (2018) Cinnamic acid attenuates quorum sensing associated virulence factors and biofilm formation in Pseudomonas aeruginosa PAO1. Biotechnol Lett 40(7):1087\u20131100. https:\/\/doi.org\/10.1007\/s10529-018-2557-9","journal-title":"Biotechnol Lett"},{"issue":"2","key":"4850_CR127","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3390\/biom12020306","volume":"12","author":"JS Ram\u00edrez-Larrota","year":"2022","unstructured":"Ram\u00edrez-Larrota JS, Eckhard U (2022) An introduction to bacterial biofilms and their proteases, and their roles in host infection and immune evasion. Biomolecules 12(2):306","journal-title":"Biomolecules"},{"issue":"2","key":"4850_CR128","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijmm.2006.02.005","volume":"296","author":"TB Rasmussen","year":"2006","unstructured":"Rasmussen TB, Givskov M (2006) Quorum-sensing inhibitors as anti-pathogenic drugs. Int J Med Microbiol 296(2):149\u2013161. https:\/\/doi.org\/10.1016\/j.ijmm.2006.02.005","journal-title":"Int J Med Microbiol"},{"issue":"4","key":"4850_CR129","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s42770-021-00624-x","volume":"52","author":"MA Rather","year":"2021","unstructured":"Rather MA, Gupta K, Mandal M (2021) Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies. Braz J Microbiol 52(4):1701\u20131718. https:\/\/doi.org\/10.1007\/s42770-021-00624-x","journal-title":"Braz J Microbiol"},{"issue":"5","key":"4850_CR130","first-page":"416","volume":"8","author":"P Rathinam","year":"2018","unstructured":"Rathinam P, Viswanathan P (2018) Anti-virulence potential of eugenol-rich fraction of Syzygium aromaticum against multidrug resistant uropathogens isolated from catheterized patients. Avicenna J Phytomed 8(5):416\u2013431","journal-title":"Avicenna J Phytomed"},{"key":"4850_CR131","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1575421","author":"J Raya","year":"2025","unstructured":"Raya J, Montagut E-J, Marco M-P (2025) Analysing the integrated quorum sensing (iqs) system and its potential role in Pseudomonas aeruginosa pathogenesis. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2025.1575421","journal-title":"Front Cell Infect Microbiol"},{"key":"4850_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1575421","volume":"15","author":"J Raya","year":"2025","unstructured":"Raya J, Montagut EJ, Marco MP (2025) Analysing the integrated quorum sensing system its potential role in Pseudomonas aeruginosa pathogenesis. Front Cell Infect Microbiol 15:1575421. https:\/\/doi.org\/10.3389\/fcimb.2025.1575421","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"4850_CR133","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-023-12890-w","volume":"108","author":"Y Ren","year":"2024","unstructured":"Ren Y, Zhu R, You X, Li D, Guo M, Fei B, Liu Y, Yang X, Liu X, Li Y (2024) Quercetin: a promising virulence inhibitor of Pseudomonas aeruginosa LasB in vitro. Appl Microbiol Biotechnol 108(1):57. https:\/\/doi.org\/10.1007\/s00253-023-12890-w","journal-title":"Appl Microbiol Biotechnol"},{"issue":"18","key":"4850_CR134","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s40265-021-01635-6","volume":"81","author":"D Reynolds","year":"2021","unstructured":"Reynolds D, Kollef M (2021) The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: an update. Drugs 81(18):2117\u20132131","journal-title":"Drugs"},{"issue":"8","key":"4850_CR135","doi-asserted-by":"publisher","first-page":"e3000805","DOI":"10.1371\/journal.pbio.3000805","volume":"18","author":"C Rezzoagli","year":"2020","unstructured":"Rezzoagli C, Archetti M, Mignot I, Baumgartner M, K\u00fcmmerli R (2020) Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa. PLoS Biol 18(8):e3000805. https:\/\/doi.org\/10.1371\/journal.pbio.3000805","journal-title":"PLoS Biol"},{"issue":"5","key":"4850_CR136","doi-asserted-by":"publisher","first-page":"107323","DOI":"10.1016\/j.ijantimicag.2024.107323","volume":"64","author":"B Rodr\u00edguez-Urretavizcaya","year":"2024","unstructured":"Rodr\u00edguez-Urretavizcaya B, Vilaplana L, Marco MP (2024) Strategies for quorum sensing Inhibition as a tool for controlling Pseudomonas aeruginosa infections. Int J Antimicrob Agents 64(5):107323. https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107323","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"4850_CR137","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3390\/molecules23030624","volume":"23","author":"L Romeo","year":"2018","unstructured":"Romeo L, Iori R, Rollin P, Bramanti P, Mazzon E (2018) Isothiocyanates: an overview of their antimicrobial activity against human infections. Molecules 23(3):624. https:\/\/www.mdpi.com\/1420-3049\/23\/3\/624","journal-title":"Molecules"},{"key":"4850_CR138","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012427","author":"ST Rutherford","year":"2012","unstructured":"Rutherford ST, Bassler BL (2012) Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a012427","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"4850_CR139","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1080\/21691401.2019.1626864","volume":"47","author":"M Salman","year":"2019","unstructured":"Salman M, Rizwana R, Khan H, Munir I, Hamayun M, Iqbal A, Rehman A, Amin K, Ahmed G, Khan M, Khan A, Amin FU (2019) Synergistic effect of silver nanoparticles and polymyxin B against biofilm produced by Pseudomonas aeruginosa isolates of pus samples in vitro. Artif Cells Nanomed Biotechnol 47(1):2465\u20132472. https:\/\/doi.org\/10.1080\/21691401.2019.1626864","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"10","key":"4850_CR140","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41579-022-00767-0","volume":"20","author":"K Sauer","year":"2022","unstructured":"Sauer K, Stoodley P, Goeres DM, Hall-Stoodley L, Burm\u00f8lle M, Stewart PS, Bjarnsholt T (2022) The biofilm life cycle: expanding the conceptual model of biofilm formation. Nat Rev Microbiol 20(10):608\u2013620. https:\/\/doi.org\/10.1038\/s41579-022-00767-0","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"4850_CR141","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/1462-2920.16328","volume":"25","author":"IJ Schalk","year":"2023","unstructured":"Schalk IJ, Perraud Q (2023) Pseudomonas aeruginosa and its multiple strategies to access iron. Environ Microbiol 25(4):811\u2013831. https:\/\/doi.org\/10.1111\/1462-2920.16328","journal-title":"Environ Microbiol"},{"issue":"8","key":"4850_CR142","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s00203-022-03068-5","volume":"204","author":"H Selim","year":"2022","unstructured":"Selim H, Radwan TEE, Reyad AM (2022) Regulation of T3SS synthesis, assembly and secretion in Pseudomonas aeruginosa. Arch Microbiol 204(8):468. https:\/\/doi.org\/10.1007\/s00203-022-03068-5","journal-title":"Arch Microbiol"},{"issue":"11","key":"4850_CR143","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1089\/mdr.2022.0134","volume":"28","author":"N Shakour","year":"2022","unstructured":"Shakour N, Taheri E, Rajabian F, Tarighi S, Soheili V, Hadizadeh F (2022) Evaluating the antivirulence effects of new Thiazolidinedione compounds against Pseudomonas aeruginosa PAO1. Microb Drug Resist 28(11):1003\u20131018. https:\/\/doi.org\/10.1089\/mdr.2022.0134","journal-title":"Microb Drug Resist"},{"key":"4850_CR144","doi-asserted-by":"publisher","unstructured":"Shariati A, Noei M, Askarinia M, Khoshbayan A, Farahani A, Chegini Z (2024) Inhibitory effect of natural compounds on quorum sensing system in Pseudomonas aeruginosa: a helpful promise for managing biofilm community . Frontiers in Pharmacology. 15\u20132024. https:\/\/doi.org\/10.3389\/fphar.2024.1350391","DOI":"10.3389\/fphar.2024.1350391"},{"key":"4850_CR145","doi-asserted-by":"publisher","first-page":"107781","DOI":"10.1016\/j.micpath.2025.107781","volume":"206","author":"B Sharma","year":"2025","unstructured":"Sharma B, Chadha J, Khullar L, Rashpa S, Harjai K (2025) FDA-approved drugs for targeting virulence of Pseudomonas aeruginosa: A drug repurposing approach to combat multidrug resistance. Microb Pathog 206:107781. https:\/\/doi.org\/10.1016\/j.micpath.2025.107781","journal-title":"Microb Pathog"},{"issue":"8","key":"4850_CR146","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/microbiolres16080183","volume":"16","author":"B Singh","year":"2025","unstructured":"Singh B, Dahiya M, Kumar V, Ayyagari A, Chaudhari DN, Ahire JJ (2025) Biofilm and antimicrobial resistance: mechanisms, implications, and emerging solutions. Microbiol Res 16(8):183. https:\/\/www.mdpi.com\/2036-7481\/16\/8\/183","journal-title":"Microbiol Res"},{"issue":"10","key":"4850_CR147","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1172\/jci20364","volume":"112","author":"RS Smith","year":"2003","unstructured":"Smith RS, Iglewski BH (2003) Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target. J Clin Invest 112(10):1460\u20131465. https:\/\/doi.org\/10.1172\/jci20364","journal-title":"J Clin Invest"},{"issue":"1","key":"4850_CR148","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1186\/s12866-025-04298-5","volume":"25","author":"W Song","year":"2025","unstructured":"Song W, Tian Z, Wang Y, Yin Y, Zhang H, Xu C, Shen L (2025) Isoliquiritigenin targets las, rhl, and Pqs quorum sensing systems to mitigate the virulence and infection of Pseudomonas aeruginosa. BMC Microbiol 25(1):580. https:\/\/doi.org\/10.1186\/s12866-025-04298-5","journal-title":"BMC Microbiol"},{"issue":"4","key":"4850_CR149","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1365-2958.2011.07620.x","volume":"80","author":"E Sonnleitner","year":"2011","unstructured":"Sonnleitner E, Gonzalez N, Sorger-Domenigg T, Heeb S, Richter AS, Backofen R, Williams P, H\u00fcttenhofer A, Haas D, Bl\u00e4si U (2011) The small RNA PhrS stimulates synthesis of the Pseudomonas aeruginosa quinolone signal. Mol Microbiol 80(4):868\u2013885. https:\/\/doi.org\/10.1111\/j.1365-2958.2011.07620.x","journal-title":"Mol Microbiol"},{"issue":"4","key":"4850_CR150","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s13213-011-0273-y","volume":"61","author":"T Strateva","year":"2011","unstructured":"Strateva T, Mitov I (2011) Contribution of an arsenal of virulence factors to pathogenesis of Pseudomonas aeruginosa infections. Ann Microbiol 61(4):717\u2013732. https:\/\/doi.org\/10.1007\/s13213-011-0273-y","journal-title":"Ann Microbiol"},{"issue":"5","key":"4850_CR151","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/iej.13050","volume":"52","author":"RCD Swimberghe","year":"2019","unstructured":"Swimberghe RCD, Coenye T, De Moor RJG, Meire MA (2019) Biofilm model systems for root Canal disinfection: a literature review. Int Endod J 52(5):604\u2013628. https:\/\/doi.org\/10.1111\/iej.13050","journal-title":"Int Endod J"},{"issue":"4","key":"4850_CR152","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1128\/iai.68.4.1834-1839.2000","volume":"68","author":"H Takase","year":"2000","unstructured":"Takase H, Nitanai H, Hoshino K, Otani T (2000) Impact of siderophore production on Pseudomonas aeruginosa infections in immunosuppressed mice. Infect Immun 68(4):1834\u20131839. https:\/\/doi.org\/10.1128\/iai.68.4.1834-1839.2000","journal-title":"Infect Immun"},{"issue":"1","key":"4850_CR153","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1186\/s12879-025-11399-z","volume":"25","author":"E Tamrat","year":"2025","unstructured":"Tamrat E, Asmare Z, Geteneh A, Sisay A, Getachew E, Kassanew B, Dessale M, Gashaw Y, Jemal A, Gashaw M, Bazezew A, Gedfie S, Kassahun W, Abebe W, Dejazmach Z, Misganaw T, Ashagre A, Nigatie M, Damtie AA, Reta MA (2025) The global prevalence of biofilm-forming Enterococcus faecalis in clinical isolates: a systematic review and meta-analysis. BMC Infect Dis 25(1):981. https:\/\/doi.org\/10.1186\/s12879-025-11399-z","journal-title":"BMC Infect Dis"},{"issue":"11","key":"4850_CR154","doi-asserted-by":"publisher","first-page":"6648","DOI":"10.1128\/aac.02620-13","volume":"58","author":"SY Tan","year":"2014","unstructured":"Tan SY, Liu Y, Chua SL, Vejborg RM, Jakobsen TH, Chew SC, Li Y, Nielsen TE, Tolker-Nielsen T, Yang L, Givskov M (2014) Comparative systems biology analysis to study the mode of action of the isothiocyanate compound Iberin on Pseudomonas aeruginosa. Antimicrob Agents Chemother 58(11):6648\u20136659. https:\/\/doi.org\/10.1128\/aac.02620-13","journal-title":"Antimicrob Agents Chemother"},{"key":"4850_CR155","doi-asserted-by":"publisher","first-page":"115689","DOI":"10.1016\/j.bcp.2023.115689","volume":"215","author":"M Thakur","year":"2023","unstructured":"Thakur M, Khushboo, Kumar Y, Yadav V, Pramanik A, Dubey KK (2023) Understanding resistance acquisition by Pseudomonas aeruginosa and possible Pharmacological approaches in palliating its pathogenesis. Biochem Pharmacol 215:115689. https:\/\/doi.org\/10.1016\/j.bcp.2023.115689","journal-title":"Biochem Pharmacol"},{"issue":"22","key":"4850_CR156","doi-asserted-by":"publisher","first-page":"8671","DOI":"10.3390\/ijms21228671","volume":"21","author":"MTT Thi","year":"2020","unstructured":"Thi MTT, Wibowo D, Rehm BHA (2020) Pseudomonas aeruginosa biofilms. Int J Mol Sci 21(22):8671. https:\/\/www.mdpi.com\/1422-0067\/21\/22\/8671","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4850_CR157","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1099\/mic.0.000692","volume":"164","author":"SH Topa","year":"2018","unstructured":"Topa SH, Subramoni S, Palombo EA, Kingshott P, Rice SA, Blackall LL (2018) Cinnamaldehyde disrupts biofilm formation and swarming motility of Pseudomonas aeruginosa. Microbiology 164(9):1087\u20131097. https:\/\/doi.org\/10.1099\/mic.0.000692","journal-title":"Microbiology"},{"key":"4850_CR158","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10020175","author":"G Topka-Bielecka","year":"2021","unstructured":"Topka-Bielecka G, Dydecka A, Necel A, Bloch S, Nejman-Fale\u0144czyk B, W\u0119grzyn G, W\u0119grzyn A (2021) Bacteriophage-derived depolymerases against bacterial biofilm. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics10020175","journal-title":"Antibiotics"},{"issue":"1","key":"4850_CR159","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/2210303106666160506120057","volume":"6","author":"M Totsika","year":"2016","unstructured":"Totsika M (2016) Benefits and challenges of antivirulence antimicrobials at the dawn of the post-antibiotic era. Drug Delivery Lett 6(1):30\u201337","journal-title":"Drug Delivery Lett"},{"issue":"8","key":"4850_CR160","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.3390\/microorganisms13081838","volume":"13","author":"A Touati","year":"2025","unstructured":"Touati A, Ibrahim NA, Tighilt L, Idres T (2025) Anti-QS strategies against Pseudomonas aeruginosa infections. Microorganisms 13(8):1838. https:\/\/www.mdpi.com\/2076-2607\/13\/8\/1838","journal-title":"Microorganisms"},{"issue":"3","key":"4850_CR161","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/pathogens11030300","volume":"11","author":"FF Tuon","year":"2022","unstructured":"Tuon FF, Dantas LR, Suss PH, Tasca Ribeiro VS (2022) Pathogenesis of the pseudomonas aeruginosa biofilm: a review. Pathogens 11(3):300. https:\/\/www.mdpi.com\/2076-0817\/11\/3\/300","journal-title":"Pathogens"},{"issue":"3","key":"4850_CR162","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000494069","volume":"11","author":"MV Turkina","year":"2019","unstructured":"Turkina MV, Vikstr\u00f6m E (2019) Bacteria-Host crosstalk: sensing of the quorum in the context of Pseudomonas aeruginosa infections. J Innate Immun 11(3):263\u2013279. https:\/\/doi.org\/10.1159\/000494069","journal-title":"J Innate Immun"},{"issue":"1","key":"4850_CR163","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/antibiotics10010003","volume":"10","author":"C Uru\u00e9n","year":"2021","unstructured":"Uru\u00e9n C, Chopo-Escuin G, Tommassen J, Mainar-Jaime R. C., Arenas J (2021) Biofilms as promoters of bacterial antibiotic resistance and tolerance. Antibiotics 10(1):3. https:\/\/www.mdpi.com\/2079-6382\/10\/1\/3","journal-title":"Antibiotics"},{"issue":"1","key":"4850_CR164","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12941-023-00639-2","volume":"22","author":"H Valadbeigi","year":"2023","unstructured":"Valadbeigi H, Sadeghifard N, Kaviar VH, Haddadi MH, Ghafourian S, Maleki A (2023) Effect of ZnO nanoparticles on biofilm formation and gene expression of the toxin-antitoxin system in clinical isolates of Pseudomonas aeruginosa. Ann Clin Microbiol Antimicrob 22(1):89. https:\/\/doi.org\/10.1186\/s12941-023-00639-2","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"2","key":"4850_CR165","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1574-6976.2005.00012.x","volume":"30","author":"V Venturi","year":"2006","unstructured":"Venturi V (2006) Regulation of quorum sensing in Pseudomonas. FEMS Microbiol Rev 30(2):274\u2013291. https:\/\/doi.org\/10.1111\/j.1574-6976.2005.00012.x","journal-title":"FEMS Microbiol Rev"},{"issue":"3","key":"4850_CR166","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/biologics1030019","volume":"1","author":"A Vetrivel","year":"2021","unstructured":"Vetrivel A, Ramasamy M, Vetrivel P, Natchimuthu S, Arunachalam S, Kim G-S, Murugesan R (2021a) Pseudomonas aeruginosa biofilm formation and its control. Biologics 1(3):312\u2013336. https:\/\/www.mdpi.com\/2673-8449\/1\/3\/19","journal-title":"Biologics"},{"issue":"28","key":"4850_CR167","doi-asserted-by":"publisher","first-page":"18314","DOI":"10.1021\/acsomega.1c02191","volume":"6","author":"A Vetrivel","year":"2021","unstructured":"Vetrivel A, Natchimuthu S, Subramanian V, Murugesan R (2021b) High-Throughput virtual screening for a new class of antagonist targeting LasR of Pseudomonas aeruginosa. ACS Omega 6(28):18314\u201318324. https:\/\/doi.org\/10.1021\/acsomega.1c02191","journal-title":"ACS Omega"},{"issue":"3","key":"4850_CR168","doi-asserted-by":"publisher","first-page":"35","DOI":"10.20517\/mrr.2025.31","volume":"4","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yu Y (2025) Phage therapy as a revitalized weapon for treating clinical diseases. Microbiome Res Rep 4(3):35. https:\/\/doi.org\/10.20517\/mrr.2025.31","journal-title":"Microbiome Res Rep"},{"issue":"7","key":"4850_CR169","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00284-025-04283-1","volume":"82","author":"A Warrier","year":"2025","unstructured":"Warrier A, Satyamoorthy K, Murali TS (2025) Naringenin as a potent natural biofilm inhibitor of Pseudomonas aeruginosa in diabetic foot ulcers through LasR competitive Inhibition. Curr Microbiol 82(7):305. https:\/\/doi.org\/10.1007\/s00284-025-04283-1","journal-title":"Curr Microbiol"},{"issue":"1","key":"4850_CR170","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00253-024-13067-9","volume":"108","author":"F Wen","year":"2024","unstructured":"Wen F, Wu Y, Yuan Y, Yang X, Ran Q, Gan X, Guo Y, Wang X, Chu Y, Zhao K (2024) Discovery of psoralen as a quorum sensing inhibitor suppresses Pseudomonas aeruginosa virulence. Appl Microbiol Biotechnol 108(1):222. https:\/\/doi.org\/10.1007\/s00253-024-13067-9","journal-title":"Appl Microbiol Biotechnol"},{"issue":"5","key":"4850_CR171","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/j.1365-2958.2005.04479.x","volume":"55","author":"CB Whitchurch","year":"2005","unstructured":"Whitchurch CB, Beatson SA, Comolli JC, Jakobsen T, Sargent JL, Bertrand JJ, West J, Klausen M, Waite LL, Kang PJ, Tolker-Nielsen T, Mattick JS, Engel JN (2005) Pseudomonas aeruginosa fimL regulates multiple virulence functions by intersecting with Vfr-modulated pathways. Mol Microbiol 55(5):1357\u20131378. https:\/\/doi.org\/10.1111\/j.1365-2958.2005.04479.x","journal-title":"Mol Microbiol"},{"key":"4850_CR172","doi-asserted-by":"publisher","unstructured":"Yang R, Guan Y, Zhou J, Sun B, Wang Z, Chen H, He Z, Jia A (2018) Phytochemicals from camellia nitidissima Chi flowers reduce the pyocyanin production and motility of Pseudomonas aeruginosa PAO1 . Frontiers in microbiology. 8\u20132017. https:\/\/doi.org\/10.3389\/fmicb.2017.02640","DOI":"10.3389\/fmicb.2017.02640"},{"key":"4850_CR173","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8638103","volume":"2020","author":"M Yang","year":"2020","unstructured":"Yang M, Meng F, Gu W, Li F, Tao Y, Zhang Z, Zhang F, Yang X, Li J, Yu J (2020) Effects of natural products on bacterial communication and network-quorum sensing. Biomed Res Int 2020:8638103. https:\/\/doi.org\/10.1155\/2020\/8638103","journal-title":"Biomed Res Int"},{"key":"4850_CR174","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00461","volume":"7","author":"O Yildirim","year":"2016","unstructured":"Yildirim O, Gottwald M, Sch\u00fcler P, Michel MC (2016) Opportunities and challenges for drug development: public-private partnerships, adaptive designs and big data. Front Pharmacol 7:461. https:\/\/doi.org\/10.3389\/fphar.2016.00461","journal-title":"Front Pharmacol"},{"key":"4850_CR175","doi-asserted-by":"publisher","unstructured":"Yin R, Cheng J, Wang J, Li P, Lin J (2022) Treatment of Pseudomonas aeruginosa infectious biofilms: challenges and strategies. Frontiers in microbiology. 13\u20132022. https:\/\/doi.org\/10.3389\/fmicb.2022.955286","DOI":"10.3389\/fmicb.2022.955286"},{"key":"4850_CR176","doi-asserted-by":"publisher","DOI":"10.3390\/biology14070859","author":"D Zeng","year":"2025","unstructured":"Zeng D, Jiao F, Yang Y, Dou S, Yu J, Yu X, Zhou Y, Xue J, Li X, Duan H, Zhang Y, Guo J, Yang W (2025) Myricetin potentiates antibiotics against resistant <Emphasis Type=\"Italic\">Pseudomonas aeruginosa<\/Emphasis> by disrupting biofilm formation and inhibiting motility through FimX-mediated c-di-GMP signaling interference. Biology. https:\/\/doi.org\/10.3390\/biology14070859","journal-title":"Biology"},{"key":"4850_CR177","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1007\/s00284-021-02589-4","volume":"78","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Zhang X (2021) Evolution of subfamily I. 1 lipases in Pseudomonas aeruginosa. Curr Microbiol 78:3494\u20133504","journal-title":"Curr Microbiol"},{"key":"4850_CR178","doi-asserted-by":"publisher","unstructured":"Zhang K, Li X, Yu C, Wang Y (2020) Promising therapeutic strategies against microbial biofilm challenges . Front Cell Infect Microbiol 10\u20132020. https:\/\/doi.org\/10.3389\/fcimb.2020.00359","DOI":"10.3389\/fcimb.2020.00359"},{"key":"4850_CR179","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26061497","author":"P Zhang","year":"2021","unstructured":"Zhang P, Guo Q, Wei Z, Yang Q, Guo Z, Shen L, Duan K, Chen L (2021) Baicalin represses type three secretion system of <Emphasis Type=\"Italic\">Pseudomonas aeruginosa<\/Emphasis> through PQS system. Molecules. https:\/\/doi.org\/10.3390\/molecules26061497","journal-title":"Molecules"},{"issue":"3","key":"4850_CR180","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1111\/jam.15640","volume":"133","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Lin S, Fu J, Zhang W, Shu G, Lin J, Li H, Xu F, Tang H, Peng G, Zhao L, Chen S, Fu H (2022) Nanocarriers for combating biofilms: advantages and challenges. J Appl Microbiol 133(3):1273\u20131287. https:\/\/doi.org\/10.1111\/jam.15640","journal-title":"J Appl Microbiol"},{"key":"4850_CR181","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/j.csbj.2023.03.013","volume":"21","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chew BLA, Wang J, Yuan M, Yam JKH, Luo D, Yang L (2023) Structural basis for the inhibitory mechanism of auranofin and gold(I) analogues against Pseudomonas aeruginosa global virulence factor regulator Vfr. Comput Struct Biotechnol J 21:2137\u20132146. https:\/\/doi.org\/10.1016\/j.csbj.2023.03.013","journal-title":"Comput Struct Biotechnol J"},{"key":"4850_CR182","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1619626","volume":"16","author":"X Zhang","year":"2025","unstructured":"Zhang X, Zhang D, Zhou D, Zheng S, Li S, Hou Q, Li G, Han H (2025) A comprehensive review of the pathogenic mechanisms of Pseudomonas aeruginosa: synergistic effects of virulence factors, quorum sensing, and biofilm formation. Front Microbiol 16:1619626. https:\/\/doi.org\/10.3389\/fmicb.2025.1619626","journal-title":"Front Microbiol"},{"issue":"1","key":"4850_CR183","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijantimicag.2018.03.002","volume":"52","author":"JW Zhou","year":"2018","unstructured":"Zhou JW, Chen TT, Tan XJ, Sheng JY, Jia AQ (2018) Can the quorum sensing inhibitor resveratrol function as an aminoglycoside antibiotic accelerant against Pseudomonas aeruginosa? Int J Antimicrob Agents 52(1):35\u201341. https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.03.002","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"4850_CR184","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1128\/iai.01772-05","volume":"74","author":"L Zulianello","year":"2006","unstructured":"Zulianello L, Canard C, K\u00f6hler T, Caille D, Lacroix JS, Meda P (2006) Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosa. Infect Immun 74(6):3134\u20133147. https:\/\/doi.org\/10.1128\/iai.01772-05","journal-title":"Infect Immun"}],"container-title":["World Journal of Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-026-04850-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11274-026-04850-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-026-04850-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:07:02Z","timestamp":1775743622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11274-026-04850-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":184,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["4850"],"URL":"https:\/\/doi.org\/10.1007\/s11274-026-04850-z","relation":{},"ISSN":["1573-0972"],"issn-type":[{"value":"1573-0972","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research paper does not contain any studies with human participants or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}